Trials / Completed
CompletedNCT04075409
A Study to Test the Safety, and Tolerability of Padsevonil in Healthy Male Japanese Study Participants
An Open-Label, Parallel Group, Single-Center Study to Investigate the Pharmacokinetic, Safety, and Tolerability Profiles of Padsevonil in CYP2C19 Genotyped Healthy Male Japanese Study Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- UCB Biopharma S.P.R.L. · Industry
- Sex
- Male
- Age
- 20 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to investigate the pharmacokinetics (PK) of padesevonil in CYP2C19 genotyped healthy male Japanese study participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Padsevonil | Padsevonil will be administered in predefined dosages. |
Timeline
- Start date
- 2019-09-30
- Primary completion
- 2019-12-27
- Completion
- 2019-12-27
- First posted
- 2019-08-30
- Last updated
- 2021-07-08
- Results posted
- 2021-07-08
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT04075409. Inclusion in this directory is not an endorsement.